The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Ser 1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Abstract
LRRK2 autophosphorylation on Ser 1292 may be a useful indicator of kinase activity, providing a readout for screening candidate LRRK2 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“The tetracycline-regulated Tet-On system was used to generate an LRRK2-expressing stable cell line (49).”
MethodBrewer, G. J., Torricelli, J. R., Evege, E. K., & Price, P. J. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490350513 · Cited by 2,325
A tissue-specific atlas of mouse protein phosphorylation and expression
Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., & Gygi, S. P. (2010) · Cell · doi:10.1016/j.cell.2010.12.001 · Cited by 1,778
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationAbsolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
Gerber, S. A., Rush, J., Stemman, O., Kirschner, M. W., & Gygi, S. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832254100 · Cited by 1,733
Beausoleil, S. A., Villén, J., Gerber, S. A., Rush, J., & Gygi, S. P. (2006) · Nature Biotechnology · doi:10.1038/nbt1240 · Cited by 1,577
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
Self-citationKinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
West, A. B., Moore, D. J., Choi, C., Andrabi, S. A., Li, X., Dikeman, D., Biskup, S., Zhang, Z., Lim, K.-L., Dawson, V. L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl471 · Cited by 533
Self-citationRole of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells
Plowey, E. D., Cherra, S. J., Liu, Y., & Chu, C. T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05217.x · Cited by 493
Jaleel, M., Nichols, R. J., Deak, M., Campbell, D. G., Gillardon, F., Knebel, A., & Alessi, D. R. (2007) · Biochemical Journal · doi:10.1042/bj20070209 · Cited by 472
Priorities in Parkinson's disease research
Meissner, W. G., Frasier, M., Gasser, T., Goetz, C. G., Lozano, A., Piccini, P., Obeso, J. A., Rascol, O., Schapira, A., Voon, V., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3430 · Cited by 436
Alegre-Abarrategui, J., Christian, H., Lufino, M. M. P., Mutihac, R., Venda, L. L., Ansorge, O., & Wade-Martins, R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp346 · Cited by 432
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Deng, X., Dzamko, N., Prescott, A., Davies, P., Liu, Q., Yang, Q., Lee, J.-D., Patricelli, M. P., Nomanbhoy, T. K., Alessi, D. R., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.538 · Cited by 417
Ramonet, D., Daher, J. P. L., Lin, B. M., Stafa, K., Kim, J., Banerjee, R., Westerlund, M., Pletnikova, O., Glauser, L., Yang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018568 · Cited by 405
Dzamko, N., Deak, M., Hentati, F., Reith, A. D., Prescott, A. R., Alessi, D. R., & Nichols, R. J. (2010) · Biochemical Journal · doi:10.1042/bj20100784 · Cited by 372
Herzig, M. C., Kolly, C., Persohn, E., Theil, D., Schweizer, T., Hafner, T., Stemmelen, C., Troxler, T. J., Schmid, P., Danner, S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr348 · Cited by 360
Li, X., Patel, J. C., Wang, J., Avshalumov, M. V., Nicholson, C., Buxbaum, J. D., Elder, G. A., Rice, M. E., & Yue, Z. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5604-09.2010 · Cited by 341
Self-citationProgressive degeneration of human neural stem cells caused by pathogenic LRRK2
Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W., et al. (2012) · Nature · doi:10.1038/nature11557 · Cited by 339 · cited 1×
“Recently, it was suggested that LRRK2 PD mutations cause defects in nuclear envelope organization (34).”
BackgroundInhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Lee, B. D., Shin, J.-H., VanKampen, J., Petrucelli, L., West, A. B., Ko, H. S., Lee, Y.-I., Maguire-Zeiss, K. A., Bowers, W. J., Federoff, H. J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2199 · Cited by 329
Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP
Gómez-Suaga, P., Luzón-Toro, B., Churamani, D., Zhang, L., Bloor-Young, D., Patel, S., Woodman, P. G., Churchill, G. C., & Hilfiker, S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr481 · Cited by 312
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Lewis, P. A., Greggio, E., Beilina, A., Jain, S., Baker, A., & Cookson, M. R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.006 · Cited by 273
Leucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
Greggio, E., & Cookson, M. R. (2009) · ASN Neuro · doi:10.1042/an20090007 · Cited by 272
Ito, G., Okai, T., Fujino, G., Takeda, K., Ichijo, H., Katada, T., & Iwatsubo, T. (2007) · Biochemistry · doi:10.1021/bi061960m · Cited by 263
Etiology of Parkinson’s disease
Schapira, A. H. V. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s10 · Cited by 250
Li, X., Tan, Y., Poulose, S., Olanow, C. W., Huang, X., & Yue, Z. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04743.x · Cited by 230
Self-citationGuo, L., Gandhi, P. N., Wang, W., Petersen, R. B., Wilson-Delfosse, A. L., & Chen, S. G. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.007 · Cited by 208
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
Nichols, R. J., Dzamko, N., Hutti, J. E., Cantley, L. C., Deak, M., Moran, J., Bamborough, P., Reith, A. D., & Alessi, D. R. (2009) · Biochemical Journal · doi:10.1042/bj20091035 · Cited by 197
LRRK2 Parkinson disease mutations enhance its microtubule association
Kett, L. R., Boassa, D., Ho, C. C.-Y., Rideout, H. J., Hu, J., Terada, M., Ellisman, M., & Dauer, W. T. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr526 · Cited by 196
Dächsel, J. C., & Farrer, M. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.79 · Cited by 171
Ramsden, N. G., Perrin, J., Ren, Z., Lee, B. D., Zinn, N., Dawson, V. L., Tam, D., Bova, M. P., Lang, M., Drewes, G., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb2002413 · Cited by 168
The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
Greggio, E., Taymans, J., Zhen, Y., Ryder, J. W., Vancraenenbroeck, R., Beilina, A. G., Sun, P., Deng, J., Jaffe, H., Baekelandt, V., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.163 · Cited by 159
Gloeckner, C. J., Boldt, K., von Zweydorf, F., Helm, S., Wiesent, L., Sarioglu, H., & Ueffing, M. (2010) · Journal of Proteome Research · doi:10.1021/pr9008578 · Cited by 155
Improved Quantitative Mass Spectrometry Methods for Characterizing Complex Ubiquitin Signals
Phu, L., Izrael-Tomasevic, A., Matsumoto, M. L., Bustos, D. J., Dynek, J. N., Fedorova, A. V., Bakalarski, C. E., Arnott, D. P., Deshayes, K., Dixit, V. M., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.003756 · Cited by 150
Self-citationWebber, P. J., Smith, A. D., Sen, S., Renfrow, M. B., Mobley, J. A., & West, A. B. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.07.033 · Cited by 149
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant
Daniëls, V., Vancraenenbroeck, R., Law, B. M. H., Greggio, E., Lobbestael, E., Gao, F., Maeyer, M. D., Cookson, M., Harvey, K., Baekelandt, V., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07105.x · Cited by 137
Identification of the Autophosphorylation Sites of LRRK2
Kamikawaji, S., Ito, G., & Iwatsubo, T. (2009) · Biochemistry · doi:10.1021/bi9011379 · Cited by 123
Taymans, J., Vancraenenbroeck, R., Ollikainen, P., Beilina, A. G., Lobbestael, E., Maeyer, M. D., Baekelandt, V., & Cookson, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023207 · Cited by 113
Doggett, E. A., Zhao, J., Mork, C. N., Hu, D., & Nichols, R. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07537.x · Cited by 108
Direct binding of α‐actinin enhances TRPP3 channel activity
Li, Q., Dai, X., Shen, P. Y., Wu, Y., Long, W., Chen, C. X., Hussain, Z., Wang, S., & Chen, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04940.x · Cited by 105
Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling
Chen, H., Chan, B. K., Drummond, J., Estrada, A. A., Gunzner, J. L., Liu, X., Liu, Y., Moffat, J. G., Shore, D. G., Sweeney, Z. K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300452p · Cited by 84
Self-citationLiu, M., Dobson, B., Glicksman, M. A., Yue, Z., & Stein, R. L. (2010) · Biochemistry · doi:10.1021/bi901851y · Cited by 72
Self-citationLovitt, B., VanderPorten, E. C., Sheng, Z., Zhu, H., Drummond, J., & Liu, Y. (2010) · Biochemistry · doi:10.1021/bi901726c · Cited by 52
Self-citationDrolet, R. E., Sanders, J. M., & Kern, J. T. (2011) · Journal of Neurogenetics · doi:10.3109/01677063.2011.627072 · Cited by 49
Yue, Z., & Lachenmayer, M. L. (2011) · Movement Disorders · doi:10.1002/mds.23737 · Cited by 46
Self-citation
Cited by
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Steger, M., Tonelli, F., Ito, G., Davies, P., Trost, M., Vetter, M., Wachter, S., Lorentzen, E., Duddy, G., Wilson, S., et al. (2016) · eLife · doi:10.7554/elife.12813 · Cited by 1,042
Protein transmission in neurodegenerative disease
Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0333-7 · Cited by 625
LRRK2 activation in idiopathic Parkinson’s disease
Di Maio, R., Hoffman, E. K., Rocha, E. M., Keeney, M. T., Sanders, L. H., De Miranda, B. R., Zharikov, A., Van Laar, A., Stepan, A. F., Lanz, T. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5429 · Cited by 564
Steger, M., Diez, F., Dhekne, H. S., Lis, P., Nirujogi, R. S., Karayel, O., Tonelli, F., Martinez, T. N., Lorentzen, E., Pfeffer, S. R., et al. (2017) · eLife · doi:10.7554/elife.31012 · Cited by 482
LRRK2 in Parkinson disease: challenges of clinical trials
Tolosa, E., Vila, M., Klein, C., & Rascol, O. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0301-2 · Cited by 438
Metadata
- Authors
- Sheng, Z., Zhang, S., Bustos, D., Kleinheinz, T., Le Pichon, C. E., Dominguez, S. L., Solanoy, H. O., Drummond, J., Zhang, X., Ding, X., Cai, F., Song, Q., Li, X., Yue, Z., van der Brug, M. P., Burdick, D. J., Gunzner-Toste, J., Chen, H., Liu, X., Estrada, A. A., Sweeney, Z. K., Scearce-Levie, K., Moffat, J. G., Kirkpatrick, D. S., & Zhu, H.
- Venue
- Science Translational Medicine
- Published
- 2012-12-12
- Volume
- 4
- Issue
- 164
- Pages
- 164ra161-164ra161
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W1967900265
- Cited by
- 353
- References
- 50
- FWCI
- 11.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.